{"id":"https://openalex.org/W2028811150","doi":"https://doi.org/10.1016/j.ejps.2013.10.012","title":"Oral biopharmaceutics tools \u2013 Time for a new initiative \u2013 An introduction to the IMI project OrBiTo","display_name":"Oral biopharmaceutics tools \u2013 Time for a new initiative \u2013 An introduction to the IMI project OrBiTo","publication_year":2013,"publication_date":"2013-11-01","ids":{"openalex":"https://openalex.org/W2028811150","doi":"https://doi.org/10.1016/j.ejps.2013.10.012","mag":"2028811150","pmid":"https://pubmed.ncbi.nlm.nih.gov/24189462"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejps.2013.10.012","doi":"https://doi.org/10.1016/j.ejps.2013.10.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2013.10.012","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088832801","display_name":"Hans Lennern\u00e4s","orcid":"https://orcid.org/0000-0002-1578-5184","observed_orcids":["https://orcid.org/0000-0002-1578-5184"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"H. Lennern\u00e4s","raw_affiliation_strings":["Uppsala University, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala University, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004605882","display_name":"Leon J Aarons","orcid":"https://orcid.org/0000-0003-2704-6570","observed_orcids":["https://orcid.org/0000-0003-2704-6570"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. Aarons","raw_affiliation_strings":["University of Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080539828","display_name":"Patrick Augustijns","orcid":"https://orcid.org/0000-0003-2595-388X","observed_orcids":["https://orcid.org/0000-0003-2595-388X"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P. Augustijns","raw_affiliation_strings":["Katholische University of Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katholische University of Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035765847","display_name":"Stefania Beato","orcid":"https://orcid.org/0000-0002-1625-1440","observed_orcids":["https://orcid.org/0000-0002-1625-1440"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"S. Beato","raw_affiliation_strings":["Novartis, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103075506","display_name":"Michael B. Bolger","orcid":"https://orcid.org/0000-0002-6992-3036","observed_orcids":["https://orcid.org/0000-0002-6992-3036"]},"institutions":[{"id":"https://openalex.org/I867333293","display_name":"Simulations Plus (United States)","ror":"https://ror.org/02p0yhm49","country_code":"US","type":"company","lineage":["https://openalex.org/I867333293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Bolger","raw_affiliation_strings":["Simulations Plus, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simulations Plus, United States","institution_ids":["https://openalex.org/I867333293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064636159","display_name":"Karl J. Box","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Box","raw_affiliation_strings":["Sirius Analytical, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirius Analytical, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109081047","display_name":"Marcus Eli Brewster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Brewster","raw_affiliation_strings":["Johnson & Johnson, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042680980","display_name":"James Butler","orcid":"https://orcid.org/0000-0003-0126-967X","observed_orcids":["https://orcid.org/0000-0003-0126-967X"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Butler","raw_affiliation_strings":["GSK, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076946026","display_name":"Jennifer Dressman","orcid":"https://orcid.org/0000-0001-9066-3980","observed_orcids":["https://orcid.org/0000-0001-9066-3980","https://orcid.org/0009-0006-0148-9225"]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J. Dressman","raw_affiliation_strings":["Goethe University Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Goethe University Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066208508","display_name":"Ren\u00e9 Holm","orcid":"https://orcid.org/0000-0003-4894-7765","observed_orcids":["https://orcid.org/0000-0003-4894-7765"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"R. Holm","raw_affiliation_strings":["H. Lundbeck A/S, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103622617","display_name":"Kerstin Julia Frank","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K. Julia Frank","raw_affiliation_strings":["Boehringer-Ingelheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer-Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016274854","display_name":"Richard A. Kendall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086951","display_name":"Merck Serono Ltd. (United Kingdom)","ror":"https://ror.org/00148fb49","country_code":"GB","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210086951"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Kendall","raw_affiliation_strings":["Merck, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, United Kingdom","institution_ids":["https://openalex.org/I4210086951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007186343","display_name":"Peter Langguth","orcid":"https://orcid.org/0000-0003-3758-7581","observed_orcids":["https://orcid.org/0000-0003-3758-7581"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P. Langguth","raw_affiliation_strings":["Johannes Gutenberg University of Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johannes Gutenberg University of Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047640193","display_name":"Jens R. Sydor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128201","display_name":"AbbVie (Germany)","ror":"https://ror.org/03538jp08","country_code":"DE","type":"company","lineage":["https://openalex.org/I2948539688","https://openalex.org/I4210128201"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J. Sydor","raw_affiliation_strings":["AbbVie, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Germany","institution_ids":["https://openalex.org/I4210128201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038842105","display_name":"Anders H. Lindahl","orcid":"https://orcid.org/0000-0003-2871-5166","observed_orcids":["https://orcid.org/0000-0003-2871-5166"]},"institutions":[{"id":"https://openalex.org/I1319126558","display_name":"Medical Products Agency","ror":"https://ror.org/0356c4a29","country_code":"SE","type":"government","lineage":["https://openalex.org/I1319126558"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"A. Lindahl","raw_affiliation_strings":["Medical Products Agency, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Products Agency, Sweden","institution_ids":["https://openalex.org/I1319126558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111062599","display_name":"Mark S. McAllister","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. McAllister","raw_affiliation_strings":["Pfizer, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035905565","display_name":"Uwe Muenster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U. Muenster","raw_affiliation_strings":["Bayer Pharma AG, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma AG, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064072022","display_name":"Anette M\u00fcllertz","orcid":"https://orcid.org/0000-0003-3020-8892","observed_orcids":["https://orcid.org/0000-0003-3020-8892"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"A. M\u00fcllertz","raw_affiliation_strings":["University of Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112329114","display_name":"Krista Ojala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"K. Ojala","raw_affiliation_strings":["Orion Pharma, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088946536","display_name":"Xavier J. H. Pepin","orcid":"https://orcid.org/0000-0002-2180-5452","observed_orcids":["https://orcid.org/0000-0002-2180-5452"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"X. Pepin","raw_affiliation_strings":["Sanofi-Aventis, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi-Aventis, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072939921","display_name":"Christos I. Reppas","orcid":"https://orcid.org/0000-0002-6958-2147","observed_orcids":["https://orcid.org/0000-0002-6958-2147"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"C. Reppas","raw_affiliation_strings":["National and Kapodistrian University of Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National and Kapodistrian University of Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051566641","display_name":"Amin Rostami\u2010Hodjegan","orcid":"https://orcid.org/0000-0003-3917-844X","observed_orcids":["https://orcid.org/0000-0003-3917-844X","https://orcid.org/0000-0002-8946-3954"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Rostami-Hodjegan","raw_affiliation_strings":["Simcyp Ltd/University of Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcyp Ltd/University of Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037551478","display_name":"Miriam Verwei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148297040","display_name":"Netherlands Organisation for Applied Scientific Research","ror":"https://ror.org/01bnjb948","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I148297040"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Verwei","raw_affiliation_strings":["TNO, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TNO, Netherlands","institution_ids":["https://openalex.org/I148297040"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033197577","display_name":"Werner Weitschies","orcid":"https://orcid.org/0000-0003-3492-7747","observed_orcids":["https://orcid.org/0000-0003-3492-7747"]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. Weitschies","raw_affiliation_strings":["University of Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011109504","display_name":"CLIVE G. WILSON","orcid":"https://orcid.org/0000-0003-0040-0728","observed_orcids":["https://orcid.org/0000-0003-0040-0728"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Wilson","raw_affiliation_strings":["University of Strathclyde, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Strathclyde, United Kingdom","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041034518","display_name":"Christer Karlsson","orcid":"https://orcid.org/0000-0001-7353-5303","observed_orcids":["https://orcid.org/0000-0001-7353-5303"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"C. Karlsson","raw_affiliation_strings":["AstraZeneca R&D, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041894017","display_name":"Bertil Abrahamsson","orcid":"https://orcid.org/0000-0003-4490-7491","observed_orcids":["https://orcid.org/0000-0003-4490-7491"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"B. Abrahamsson","raw_affiliation_strings":["AstraZeneca R&D, Sweden. Electronic address: Bertil.abrahamsson@astrazeneca.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Sweden. Electronic address: Bertil.abrahamsson@astrazeneca.com","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":11,"institutions_distinct_count":23,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3070,"currency":"USD","value_usd":3070},"apc_paid":null,"fwci":1.6549,"has_fulltext":false,"cited_by_count":102,"citation_normalized_percentile":{"value":0.81619938,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"57","issue":null,"first_page":"292","last_page":"299"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gastrointestinal-drug-absorption","display_name":"gastrointestinal drug absorption","score":0.9380000233650208},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.7919999957084656},{"id":"https://openalex.org/keywords/low-solubility-drugs","display_name":"low solubility drugs","score":0.7379999756813049},{"id":"https://openalex.org/keywords/modified-release-formulation","display_name":"modified-release formulation","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.652999997138977},{"id":"https://openalex.org/keywords/pharmaceutical-formulation-development","display_name":"drug formulation development","score":0.4009999930858612}],"concepts":[{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.8500995635986328},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.6377134323120117},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.6083886623382568},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.48035845160484314},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.46921196579933167},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.45536890625953674},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.452846884727478},{"id":"https://openalex.org/C2776396487","wikidata":"https://www.wikidata.org/wiki/Q506319","display_name":"Generic drug","level":3,"score":0.4181452989578247},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.41363072395324707},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.4089146554470062},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.39803874492645264},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.380023717880249},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.35632503032684326},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3383580446243286},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32943195104599},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.27891805768013},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27380526065826416},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2214353382587433},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21375709772109985},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.1860818862915039},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.12025022506713867},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001702","descriptor_name":"Biopharmaceutics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004304","descriptor_name":"Dosage Forms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016730","descriptor_name":"Program Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D041981","descriptor_name":"Gastrointestinal Tract","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ejps.2013.10.012","doi":"https://doi.org/10.1016/j.ejps.2013.10.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2013.10.012","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:24189462","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24189462","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","raw_type":"Journal Article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/423328","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24189462","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Pharmaceutical Sciences, vol. 57 (1), Art.No. C, (292-299)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/aa06c0bd-7877-43ea-a1b5-8231695b1e62","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/aa06c0bd-7877-43ea-a1b5-8231695b1e62","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1481796766","https://openalex.org/W1490573286","https://openalex.org/W1498305210","https://openalex.org/W1499935265","https://openalex.org/W1522767714","https://openalex.org/W1535579925","https://openalex.org/W1963614011","https://openalex.org/W1974819402","https://openalex.org/W1978960033","https://openalex.org/W1979214520","https://openalex.org/W1990432963","https://openalex.org/W1991645219","https://openalex.org/W1994891003","https://openalex.org/W1997764055","https://openalex.org/W2000836282","https://openalex.org/W2004345176","https://openalex.org/W2006967678","https://openalex.org/W2022975557","https://openalex.org/W2026940252","https://openalex.org/W2028273867","https://openalex.org/W2030247333","https://openalex.org/W2040233060","https://openalex.org/W2046641531","https://openalex.org/W2050819978","https://openalex.org/W2052323048","https://openalex.org/W2069506489","https://openalex.org/W2075009832","https://openalex.org/W2080561646","https://openalex.org/W2089133581","https://openalex.org/W2090138592","https://openalex.org/W2105286149","https://openalex.org/W2114903378","https://openalex.org/W2133061394","https://openalex.org/W2149429360","https://openalex.org/W2156321359"],"related_works":["https://openalex.org/W3027036548","https://openalex.org/W3135363367","https://openalex.org/W2774663515","https://openalex.org/W2588931050","https://openalex.org/W2769601732","https://openalex.org/W2906381701","https://openalex.org/W2810783642","https://openalex.org/W2049256907","https://openalex.org/W3049726463","https://openalex.org/W2525378244"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}